← FDA DRUG APPROVALS

FDA ANDA · ANDA203345

OMEPRAZOLE AND SODIUM BICARBONATE

Sponsor: ZYDUS

APPLICATION
ANDA203345
TYPE
ANDA
ORIGINAL APPROVAL
2018-03-16
LATEST ACTION
2020-07-23
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Over-the-counter

Products

OMEPRAZOLE AND SODIUM BICARBONATEOver-the-counter
OMEPRAZOLE 20MG, SODIUM BICARBONATE 1.1GM · CAPSULE · ORAL

Approval history

2020-07-23Labeling · Supplement 1 · standardAP
2018-03-16UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →